NEW YORK (GenomeWeb News) – Software maker Temis said today that Laboratoires Fournier, a drug discovery affiliate of Solvay Pharmaceuticals, will use Temis’ Luxid text analytic solution.
 
Laboratoires Fournier will use the software in its Exploratory Biology Unit, which searches for biomarkers that could be used in Solvay’s pre-clinical drug development programs.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.

The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.

Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.

In Nature this week: ash dieback disease fungal genome, and more.